Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat

Xenobiotica

Volumn 29, Issue 12, 1999, Pages 1227-1240

  Breinholt, V ^a   Lauridsen, S T ^a   Dragsted, L O ^a  

^a DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; ANTIOXIDANT; APIGENIN; BETA NAPHTHOFLAVONE; CATALASE; CHRYSIN; DNA; DRUG METABOLIZING ENZYME; ERYTHROCYTE ENZYME; FLAVONOID; GENISTEIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEART ENZYME; LIVER ENZYME; MALONALDEHYDE; NARINGENIN; QUERCETIN; SUPEROXIDE DISMUTASE; TANGERETIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON; CONTROLLED STUDY; DIET; DNA ADDUCT; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HEART MUSCLE METABOLISM; LIVER METABOLISM; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALIA; FELIS CATUS;

EID: 0033391238     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599237903     Document Type: Article

References (49)

1. Beckman, K. B. and Ames, B. N., 1997, Oxidative decay of DNA. Journal of Biological Chemistry, 272, 19633-19366.
2. Block, G. and Langseth, L., 1994, Antioxidant vitamins and disease prevention. Food Technology, July, 80-84.
3. Bors, W. and Saran, M., 1987, Radical scavenging by flavonoid antioxidants. Free Radical Research Communications, 2, 289-294.
4. Breinholt, V., 1999, Desirable versus harmful levels of intake of flavonoids and phenolic acids. In J. T. Kumpulainen and J. T. Salonen (eds), Natural Antioxidants in Nutrition, Health and Disease (Cambridge: Royal Society of Chemistry), pp. 93-105.
5. Brouard, C., Siess, M.-H., Vernevaut, M.-F. and Suschetet, M., 1988, Comparison of the effects of feeding quercetin or flavone on hepatic and intestinal drug-metabolizing enzymes of the rat. Food and Chemical Toxicology, 26, 99-103.
6. Buening, M. K., Chang, R. L., Huang, M.-T., Fortner, J. G., Wood, A. W. and Conney, A. H., 1981, Activation and inhibition of benzo[a]pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Research, 41, 67-72.
7. Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R. and Mayers, R. T., 1994, Cytochrome P450 specificities of alkylresorufin O-dealkylation in human and rat liver. Biochemical Pharmacology, 48, 923-936.
8. Canivenc-Lavier, M.-C., Vernevaut, M.-F., Totis, M., Siess, M.-H., Magdalou, J. and Suschetet, M., 1996, Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology, 114, 19-27.
9. Chae, Y. H., Marcus, C. B., Ho, D. K., Cassady, J. M. and Baird, W. M., 1991, Effects of synthetic and naturally occurring flavonoids on benzo(a)pyrene metabolism by hepatic microsomes prepared from rats treated with cytochrome P-450 inducers. Cancer Letters, 60, 15-24.
10. Cholbi, M. R., Paya, M. and Alcaraz, M. J., 1991, Inhibitory effects of phenolic compounds on CCL4-induced microsomal lipid peroxidation. Experimentia, 47, 195-199.
11. Constant, J., 1997, Alcohol, ischemic heart disease, and the French paradox. Coronary Artery Disease, 8, 645-649.
12. Crofts, F. G, Sutter, T. R. and Strickland, P. T., 1998, Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis, 19, 1969-1973.
13. Dashwood, R. H., Arbogast, D. N., Fong, A. T., Hendricks, J. D. and Bailey, G. S., 1988, Mechanisms of anticarcinogenesis by indole-3-carbinol: Detailed in vivo DNA-binding dose-response studies after dietary administration with aflatoxin B1. Carcinogenesis, 9, 427-432.
14. Dragsted, L. O., Alexander, J., Wallin, H., Frandsen, H. and Vang. O., 1993, Bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by liver microsomes from three different rat strains. Pharmacology and Toxicology, 72, 388-393.
15. Dreher, D. and Junod, A. F., 1996, Role of oxygen free radicals in cancer development. European Journal of Cancer, 32A, 30-38.
16. Ernster, L., 1967, DT diaphorase. Methods in Enzymology, 10, 309-317.
17. Fraga, C. G., Martino, V. S., Ferraro, G. E., Coussio, J. D. and Boveris, A., 1987, Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochemical Pharmacology, 36, 717-720.
18. Fuhr, U., Klittich, K. and Staib, H., 1993, Inhibitory effects of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. British Journal of Clinical Pharmacology, 35, 431-436.
19. Goldberg, D. M. and Spooner, R. J., 1983, In Methods of Enzymatic Analysis, 3rd Edn (Deerfield Beach: Chemie), vol. 3, pp. 258-265.
20. Habig, W. H., Pabst, M. J. and Jacoby, W. B., 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249, 7130-7139.
21. Halliwell, B., 1996, Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radical Research, 25, 57-74.
22. Halliwell, B. and Gutteridge, M. C., 1990, Role of free radicals and catalytic metal ions in human disease: An overview. Methods in Enzymology, 186, 1-83.
23. Huang, M.-T., Johnson, E. F., Muller-Eberhard, U., Koop, D. R., Coon, M. J. and Conney, A. H., 1981, Specificity in the activation and inhibition by flavonoids of benzo[a]flavone hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes. Journal of Biological Chemistry, 21, 10897-10901.
24. Ito, N., Hasegawa, R., Sano, M., Tamano, S., Esumi, H., Takayama, S. and Sugimura, T., 1991, A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
25. Kaderlik, R. K., Minchin, R. F., Mulder, G. J., Ilett, K. F., Daugaard-Jenson, M., Teitel, C. H. and Kalubar, F. F., 1994, Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis, 15, 1703-1709.
26. Lake, B. G., 1987, Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. In K. Snell and B. Mullock (eds), Biochemical Toxicology: A Practical Approach (Oxford: IRL Press), pp. 183-215.
27. Lasker, J. M., Huang, M.-T. and Conney, A. H., 1983, In vitro and in vivo activation of oxidative drug metabolism by flavonoids. Journal of Pharmacology and Experimental Therapeutics, 229, 162-170.
28. Lee, H., Wang, H.-W., Su, H.-Y. and Hao, N. J., 1994, The structure-activity relationship of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinoline. Mutagenesis, 9, 101-106.
29. Li, Y., Wang, E., Patten, C. J., Chen, L. and Yang, C. S., 1994, Effects of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes. Drug Metabolism and Disposition, 22, 566-571.
30. Lonchampt, M., Guardiola, B., Sicot, N., Bertrand, M., Perdrix, L. and Duhault, J., 1989, Protective effect of purified flavonoid fraction against reactive oxygen radicals. Arzneimittel Forschung. 39, 882-885.
31. Meyer, O., Blom, L. and Sndergaard, D., 1982, The influence of minerals and protein on the nephrocalcinosis potential for rats of semi-synthetic diets. Laboratory Animals, 16, 271-273.
32. Monboisse, J. C., Braquet, P., Randoux, A. and Borel, J. P., 1983, Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: Protective effect of flavonoids. Biochemical Pharmacology, 32, 53-58.
33. Mora, A., Paya, M., Rios, J. L. and Alcaraz, M. J., 1990, Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymatic lipid peroxidation. Biochemical Pharmacology, 40, 793-797.
34. +-linked assay for microsomal uridine diphosphate glucuronyltransferase of rat liver and some observations on substrate specificity of the enzyme. Biochemical Journal, 151, 31-41.
35. Nielsen, S. E., Breinholt, V., Justesen, U., Cornett, C. and Dragsted, L. O., 1998, In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica, 28, 389-401.
36. Redinbaugh, M. G. and Rurley, R. B., 1986, Adoption of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Analytical Biochemistry, 153, 267-271.
37. Rice-Evans, C. A., Miller, N. J. and Paganga, G., 1996, Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radicals in Biology and Medicine, 20, 933-956.
38. Siess, M. H. Guillarmic, M., Le Bon, A. M. and Suschetet, M., 1989, Induction of monooxygenase and transferase activities in rat by dietary administration of flavonoids. Xenobiotica, 19, 1379-1386.
39. Siess, M. H., Brouard, Vernevaut, M. F. and Suschetet, M., 1988, Effects of feeding quercetin and flavone on hepatic drug metabolizing enzymes of rats. Progress in Clinical and Biological Research, 280, 147-150.
40. Siess, M.-H., Leclerc, J., Canivenc-Lavier, M.-C., Rat, P. and Suschetet, M., 1995, Heterogeneous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicology and Pharmacology, 130, 73-78.
41. Siess, M.-H., Mas, J.-P., Canivenc-Lavier, M.-C. and Suschetet, M., 1996, Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids. Journal of Toxicology and Environmental Health, 49, 481-496.
42. Talalay, P., 1989, Mechanisms of induction of enzymes that protect against chemical carcinogens. Advances in Enzyme Regulation, 28, 237-250.
43. Talalay, P., De Long, M. J. and Prochaska, H. J., 1987, Molecular mechanisms in protection against carcinogenesis. In J. G. Cory and A. Szentivani (eds), Cancer Biology and Therapeutics (New York: Plenum), pp. 197-216.
44. Tsyrlov, I. B., Mikhailenko, V. M. and Belboin, H. V., 1994, Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochimica et Biophysica Acta, 1205, 325-335.
45. Wang, Z. Y., Das, M., Bickers, D. R. and Mukhtar, H., 1988, Interaction of epicatechins derived from green tea with rat hepatic cytochrome P-450. Drug Metabolism and Disposition, 16, 98-103.
46. Wattenberg, L. W., 1983, Inhibition of neoplasia by minor dietary constituents. Cancer Research, 43 (suppl.), 2448s -2453s.
47. Wattenberg, L. W., 1985, Chemoprevention of cancer. Cancer Research, 45, 1-8.
48. Wheeler, C. R., Salzman, J. A., Elsayed, N. M., Omaye, S. T. and Korte, D. W., 1990, Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity.Analytical Biochemistry, 184, 193-199.
49. Zhang, Q. Y. Wikoff, J. Dunbar, D. and Kaminsky, L., 1996, Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metabolism and Disposition, 24, 322-328.